R H Reznek

1.5k citations
23 papers · 1.2k indexed · h-index 16
Topics
Neuroendocrine Tumor Research Advances (6 papers)Lung Cancer Research Studies (4 papers)Pancreatic and Hepatic Oncology Research (4 papers)

In The Last Decade

R H Reznek

23 papers receiving 1.1k citations

Peers

R H Reznek
Comparison fields: 5 of 81
  • Oncology 548
  • Epidemiology 437
  • Molecular Biology 322
  • Surgery 299
  • Endocrinology, Diabetes and Metabolism 282
Replace Paul Lo Gerfo with:
Paul Lo Gerfo United States
Esra Erden Türkiye
Manuela Roncella Italy
Christopher K. Wong United States
Joseph P. Concannon United States
John S. Carruthers Canada
Merten Hommann Germany
Simon Nayler South Africa
Christopher R. West United Kingdom
Richard S. Benua United States
R H Reznek relative to Paul Lo Gerfo United States Paul Lo Gerfo's profile →
Citations per field
00.5×
Paul Lo Gerfo · 1×
Citations per year

Countries citing papers authored by R H Reznek

Since Specialization
Citations

This map shows the geographic impact of R H Reznek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R H Reznek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R H Reznek more than expected).

Fields of papers citing papers by R H Reznek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R H Reznek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R H Reznek. The network helps show where R H Reznek may publish in the future.

Co-authorship network of co-authors of R H Reznek

This figure shows the co-authorship network connecting the top 25 collaborators of R H Reznek. A scholar is included among the top collaborators of R H Reznek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R H Reznek. R H Reznek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 31
3 29
4 134
5 3
6 93
7 22
8 6
9 29
10 24
11 130
12 15
13 25
14 2
15 102
16 30
17 6
18 392
19 10
20 12

About R H Reznek

R H Reznek is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Neurology, having authored 23 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (6 papers), Lung Cancer Research Studies (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (548 citations), Endocrinology, Diabetes and Metabolism (282 citations) and Hepatology (127 citations). R H Reznek has collaborated with scholars based in United Kingdom, Sweden and Denmark. Frequent co-authors include P. F. M. Wrigley, Peter Clark, M L Slevin, Richard J. Osborne, W. Gregory, Simran Malik, Donna Lowe, G. M. Besser, JP Monson and Peter D. Wilson. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026